申请人:Treu Matthias
公开号:US20120238542A1
公开(公告)日:2012-09-20
Compounds of general formula (I)
wherein the groups R
1
to R
3
and X are defined as in claim
1
, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, pharmaceutical preparations which contain such compounds and their use as medicaments.
通式(I)中R1至R3和X组的定义如索赔1所述,适用于治疗以细胞过度或异常增殖为特征的疾病,包含此类化合物的药物制剂以及它们作为药物的用途。